Burger's Medicinal Chemistry and Drug Discovery

Burger's Medicinal Chemistry and Drug Discovery

Online ISBN: 9780471266945

DOI: 10.1002/0471266949

Browse by Topic

  1. Antiinfectives
  2. Cancer
  3. Cardiovascular, Endocrine and Metabolic Diseases
  4. Chemotherapeutic Agents
  5. CNS Disorders
  6. Drug Development
  7. Drug Discovery
    1. ADMET In Vitro Profiling: Utility and Applications in Lead Discovery
    2. Allosteric Proteins and Drug Discovery
    3. Analog Design
    4. Approaches to the Rational Design of Enzyme Inhibitors
    5. Assessing The Bioavailability of Drug Delivery Systems: Mathematical Modeling
    6. Bioinformatics: Its Role in Drug Discovery
    7. Carbohydrate-Based Therapeutics
    8. Chemical Information Computing Systems in Drug Discovery
    9. Chemogenomics: Systematization of Drug Discovery
    10. Chirality and Biological Activity
    11. Combinatorial Chemistry and Multiple Parallel Synthesis
    12. Combinatorial Library Design, Molecular Similarity, and Diversity Applications
    13. Design of Peptidomimetics
    14. Docking and Scoring Functions/Virtual Screening
    15. Docking and Scoring in Drug Discovery
    16. Drug Discovery: The Role of Toxicology
    17. Drug-Target Binding Forces: Advances in Force Field Approaches
    18. Drug Transport and Membrane Transport Proteins
    19. Electron Cryomicroscopy of Biological Macromolecules
    20. GPCR Homology Model Development and Application
    21. High-Throughput Screening for Lead Discovery
    22. History of Quantitative Structure–Activity Relationships
    23. Mass Spectrometry and Drug Discovery
    24. Medicinal Chemistry Approaches for Multitarget Drugs
    25. Metabolic Considerations in Prodrug Design
    26. Microarrays and Gene Expression Profiling Applied to Drug Research
    27. Microbes to Man: From Soils and the Depths to Drugs
    28. Molecular Modeling in Drug Design
    29. Multiobjective Optimization for Drug Discovery
    30. Natural Products as Leads for New Pharmaceuticals
    31. New Strategies for Natural Products Lead Generation
    32. Nicotinic Acetylcholine Receptors
    33. NMR-Based Screening and Drug Discovery
    34. Oligonucleotide Therapeutics
    35. Peptidomimetics for Drug Design
    36. Pharmacophores
    37. Principles of Drug Metabolism
    38. Protein Flexibility in In Silico Screening
    39. Protein–Protein Interactions as Drug Discovery Targets
    40. QM and QM/MM Approaches to Evaluating Binding Affinities
    41. Rapid, High Content Pharmacology
    42. Recent Advances in Development, Validation, and Exploitation of QSAR Models
    43. Recent Trends in Structure-Based Drug Design and Energetics
    44. Receptor Targets in Drug Discovery
    45. Retrometabolism-Based Drug Design and Targeting
    46. Selective Toxicity
    47. SNPs: Single Nucleotide Polymorphisms and Pharmacogenomics: Individually Designed Drug Therapy
    48. Structural Alerts for Toxicity
    49. Structural Concepts in the Prediction of the Toxicity of Therapeutical Agents
    50. Structural Genomics, Its Application in Chemistry, Biology, and Drug Discovery
    51. Structure-Based Drug Design
    52. The Application of Recombinant DNA Technology in Medicinal Chemistry and Drug Discovery
    53. Use of Biological Fingerprints Versus Structure/Chemotypes to Describe Molecules
    54. Virtual Screening
    55. X-Ray Crystallography in Drug Discovery
  8. Pulmonary, Bone, Vitamins and Autocoid Therapeutic Agents